{"id":10141,"date":"2014-06-10T08:37:11","date_gmt":"2014-06-10T12:37:11","guid":{"rendered":"http:\/\/www.marshall.edu\/murc\/?p=10141"},"modified":"2014-06-10T08:41:40","modified_gmt":"2014-06-10T12:41:40","slug":"biomedical-sciences-researcher-to-present-results-of-clinical-trials-on-personalized-chemotherapy","status":"publish","type":"post","link":"https:\/\/www.marshall.edu\/murc\/biomedical-sciences-researcher-to-present-results-of-clinical-trials-on-personalized-chemotherapy\/","title":{"rendered":"Biomedical sciences researcher to present results of clinical trials"},"content":{"rendered":"

Tuesday, June 10, 2014<\/strong>\u00a0[social_share\/]\n

\n

\"Photo<\/a>HUNTINGTON, W.Va.\u00a0<\/strong>\u2013 Dr. Pier Paolo Claudio, a researcher at the Marshall University Joan C. Edwards School of Medicine, is traveling to Paphos, Cyprus, next month to present his work to personalize chemotherapy for cancer treatment.<\/p>\n

Claudio was invited to give the talk at the 5th International Conference on Recent Advances in Health and Medical Sciences<\/a>, which will be held July 6-12.<\/p>\n

He will be discussing the results of clinical trials conducted at the Edwards Comprehensive Cancer Center. The studies tested ChemoID, a cell culture method he developed with colleague Dr. Jagan Valluri to measure the sensitivity of patients\u2019 tumors to chemotherapy treatment for lung, brain\/spine and breast cancer.<\/p>\n

He says more evaluation of the technology is needed, but preliminary tests on a small number of patients found ChemoID 100 percent accurate in predicting which drug is more effective in treating patients affected by brain cancer if the tumor-initiating cancer stem cells were evaluated.<\/p>\n

\u201cOncologists every day face many challenges in determining the best course of therapy for an individual cancer patient,\u201d says Claudio. \u201cThe basic problem is that patients with similar diagnoses don\u2019t always respond to the same chemotherapy. This technology we have developed could help physicians select the appropriate chemotherapy for an individual patient\u2014giving them an edge in the fight against cancer.\u201d<\/p>\n

He says the good news for cancer patients is that ChemoID may make possible personalized treatment by predicting the most effective drug combination to successfully target that specific patient\u2019s cancer\u2014increasing the chance the drugs will work and perhaps reducing side effects by helping the patient avoid unnecessary drugs.<\/p>\n

In addition to presenting his own research at the conference, Claudio will be moderating a session, \u201cAdvances in Oncology and Anticancer Research. Cancer Pathology.\u201d<\/p>\n

Summaries of the research presented at the meeting will be published in the journal Frontiers in Bioscience<\/a><\/em>.<\/p>\n

\n

Contact:\u00a0\u00a0<\/a>Ginny Painter<\/a>, Communications Director, Marshall University Research Corporation, 304.746.1964<\/p>\n","protected":false},"excerpt":{"rendered":"

Tuesday, June 10, 2014\u00a0[social_share\/] HUNTINGTON, W.Va.\u00a0\u2013 Dr. Pier Paolo Claudio, a researcher at the Marshall University Joan C. Edwards School of Medicine, is traveling to Paphos, Cyprus, next month to present his work to personalize chemotherapy for cancer treatment. Claudio was invited to give the talk at the 5th International Conference on Recent Advances in<\/p>\n","protected":false},"author":15,"featured_media":10148,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10,3],"tags":[],"class_list":["post-10141","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-frontpage-slideshow","category-news"],"acf":[],"fimg_url":"https:\/\/www.marshall.edu\/murc\/files\/PierPaoloClaudio.jpg","_links":{"self":[{"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/posts\/10141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/comments?post=10141"}],"version-history":[{"count":0,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/posts\/10141\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/media\/10148"}],"wp:attachment":[{"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/media?parent=10141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/categories?post=10141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marshall.edu\/murc\/wp-json\/wp\/v2\/tags?post=10141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}